Buphenine: Difference between revisions
Content deleted Content added
→See also: no need to link articles that don't exist |
m →top: Protect -{ markup from preprocessor: phab:T146304, explained. using AWB Tag: nowiki added |
||
| Line 1: | Line 1: | ||
{{Drugbox |
{{Drugbox |
||
| IUPAC_name = 4-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]propyl}phenol |
| IUPAC_name = 4-<nowiki/>{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]propyl}phenol |
||
| image = Buphenine.svg |
| image = Buphenine.svg |
||
Revision as of 12:10, 11 April 2017
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.531 |
| Chemical and physical data | |
| Formula | C19H25NO2 |
| Molar mass | 299.41 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
Buphenine (or nylidrin) is a β2 adrenoreceptor agonist[1] that acts as a vasodilator.
See also
References
- ^ Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest. Ophthalmol. Vis. Sci. 26 (2): 163–9. PMID 2857689.
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |